$CDXC News Article - Newly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen , Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) Patients https://marketwirenews.com/news-releases/newl...21572.html